Pharmaceutical company Stada Arzneimittel has purchased Thornton & Ross, a British prescription-free OTC manufacturer, after Stada and the owners had already announced exclusive contract negotiations Aug. 6.

The purchase price is approximately $302 million on a so-called cash and debt-free basis. Thornton & Ross has a number of OTC branded products for a variety of indications including cold, pain and dermatology.